期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

遵循新指南规范心力衰竭防治工作 被引量：9

原文传递
导出
摘要 一、新指南产生的背景和过程 中国心力衰竭诊断和治疗指南2014（简称新指南）在本期发表。自中华医学会心血管病学分会决定修订慢性心力衰竭诊断治疗指南，直至新指南定稿发表，历时2年半。心力衰竭（心衰）学组具体负责新指南的修订和撰写工作，先后举行了10次会议，认真学习了近几年发表的欧洲心脏病协会（ESC）、
作者 黄峻 杨杰孚
机构地区 南京医科大学第一附属医院 北京医院心内科
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2014年第2期91-93,共3页 Chinese Journal of Cardiology
关键词 慢性心力衰竭 新指南 欧洲心脏病协会 防治 治疗指南 中华医学会 心血管病 诊断
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献6

  • 1中华医学会心血管病学分会,中华心血管病杂志编辑委员会[J].中国心力衰竭诊断和治疗指南2014.中华心血管病杂志,2014,42:98-122.
  • 2无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量：3691
  • 3McMurray JJ,Adamopoulps S,Anker SD,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012:the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J].Eur J Heart Fail,2012,14:803-869.
  • 4Yancy CW,Jessup M,Bozkurt B,et al.2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,62:e1 47-e239.
  • 5Swedberg K,Komajda M,B(o)hm M,et al.Ivabradine and outcomes in chronic heart failure (SHIFT):a randomised placebocontrolled study[J].Lancet,2010,376:875-885.
  • 6Zareba W,Klein H,Cygankiewicz I,et al.Effectiveness of cardiac resynchronization therapy by QRS morphology in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy(MADIT-CRT)[J].Circulation,2011,123:1061-1072.

二级参考文献42

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量：90
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.

共引文献3690

同被引文献123

  • 1张帆,蔡军.2013印度高血压指南简介[J].中国医学前沿杂志（电子版）,2013,5(6):63-68. 被引量：2
  • 2许彬,王海龙,魏开华,张学敏,杨松成.代谢组学分析技术及其在几类重大疾病研究中的应用[J].分析测试学报,2006,25(5):128-132. 被引量：15
  • 3徐燕,杨爱东,唐靖一,张玮,严世芸（指导）.严世芸治疗充血性心力衰竭的经验[J].上海中医药杂志,2006,40(10):10-11. 被引量：31
  • 4Yancy CW,Jessup M,Bozkurt B,et al.2013 ACCF/AHA guideline for the management of heart failure:a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2013,62:e147-e239.
  • 5Bui AL,Horwich TB,Fonarow GC.Epidemiology and risk profile of heart failure.Nat Rev Cardiol,2011,8:30-41.
  • 6Bmuwers FP,de Boer RA,van der Harst P,et al.Incidence and epidemiology of new onset heart failure with preserved vs.reduced ejection fraction in a community-based cohort:11-year follow-up of PREVEND.Eur Heart J,2013,34:1424-1431.
  • 7Steinberg BA,Zhao X,Heidenreich PA,et al.Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction:prevalence,therapies,and outcomes.Circulation,2012,126:65-75.
  • 8Butler J,Fonarow GC,Zile MR,et al.Developing therapies for heart failure with preserved ejection fraction:current state and future directions.JACC Heart fail,2014,2:97-112.
  • 9Bhatia RS,Tu JV,Lee DS,et al.Outcome of heart failure with preserved ejection fraction in a population-based study.N Engl J Med,2006,355:260-269.
  • 10Farr MJ,Lang CC,Lamanca JJ,et al.Cardiopulmonary exercise variables in diastolic versus systolic heart failure.Am J Cardiol,2008,102:203-206.

引证文献9

二级引证文献199

中华心血管病杂志
2014年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部